Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day
I'm PortAI, I can summarize articles.
Corbus Pharmaceuticals Holdings Inc. (CRBP) stock fell 1.80% to $8.19, despite a positive trading session for the market. The NASDAQ rose 0.57% and the Dow Jones increased 0.16%. Corbus' stock is 60.17% below its 52-week high. Competitors like Vanda Pharmaceuticals and Fortress Biotech also saw declines, while Viking Therapeutics rose. Trading volume was significantly below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments